Plantar Fibroma: Symptoms, Causes & Treatment Options

What Is a Plantar Fibroma?

Discovering a firm lump in the arch of your foot — one that doesn’t move much when you press it, isn’t particularly tender in isolation, but aches when you walk or stand — is the typical presentation of a plantar fibroma. These benign fibrous tumors arise within the substance of the plantar fascia itself, embedded in the connective tissue of the arch rather than sitting freely under the skin. They are composed of dense, proliferating fibroblasts — the same cell type responsible for scar tissue — organized into a firm nodule that is anatomically fixed to the plantar fascia.

Plantar fibromas are part of a spectrum of fibromatoses: when they are multiple, bilateral, and accompanied by similar lesions in the palm (Dupuytren’s contracture) or other fascial structures, the condition is called Ledderhose disease — a hereditary fibromatosis syndrome with autosomal dominant inheritance and variable penetrance. In our clinic, we see a mix of isolated single fibromas and the full Ledderhose presentation; the treatment approach is similar but the long-term management differs.

Causes and Risk Factors

The exact cause of plantar fibroma formation is not fully understood, but several factors are consistently associated:

• Genetics: A family history of plantar fibromas, Dupuytren’s contracture, or Peyronie’s disease (penile fibrosis — another fibromatosis) substantially increases risk. These conditions share a common underlying fibroblast dysregulation.
• Repetitive microtrauma: Repetitive tensile stress on the plantar fascia (from running, prolonged standing, barefoot walking) may trigger fibroblast proliferation at micro-injury sites within the fascia.
• Chronic plantar fasciitis: Longstanding plantar fasciitis and its associated fascia degeneration may predispose to fibroma formation in some patients.
• Medications: Chronic use of phenytoin (an anticonvulsant), beta-blockers, and glucosamine have been associated with fibromatosis.
• Liver disease and diabetes: Both are associated with increased systemic fibroblast activity and higher rates of fibromatosis conditions.
• Male sex and age 40+: Plantar fibromas are significantly more common in men; incidence peaks in the fourth to sixth decade.

Symptoms

The natural history of plantar fibromas is highly variable. Some remain small and asymptomatic for years; others grow progressively and cause significant walking limitation. The dominant symptom — when present — is arch pain from direct pressure on the nodule during weight-bearing: the fibroma is pressed between the plantar fascia and the ground with each step, producing a localized aching discomfort that worsens with prolonged standing or walking barefoot. Tight shoes that press the arch may also be painful.

Unlike plantar fasciitis, plantar fibroma pain does not follow the first-step pattern and does not improve after warming up. Unlike a plantar wart, a plantar fibroma is deep within the fascia (not in the skin), is not tender to lateral pinch compression, and has no punctate capillary bleeding when pared. The firm, non-mobile, non-tender-at-rest lump in the mid-arch is pathognomonic.

Diagnosis

Diagnosis is primarily clinical — a firm, non-tender (or mildly tender) nodule palpable within the plantar fascia in the mid-arch, moving with the fascia when the toes are dorsiflexed but not mobile freely under the skin. Ultrasound confirms the diagnosis non-invasively: the fibroma appears as a hypoechoic, well-circumscribed mass within the echogenic plantar fascia tissue, with no internal vascularity on Doppler — distinguishing it from ganglion cysts (anechoic, with enhanced through-transmission) and soft-tissue sarcomas (Doppler-positive vascular signal).

MRI is obtained when: the diagnosis is uncertain, the mass is large or rapidly growing (to exclude malignant soft-tissue tumors), surgical planning is being considered (to map the mass’s full extent within the fascia), or multiple masses suggest Ledderhose disease requiring staging. On MRI, plantar fibromas are typically hypointense on both T1 and T2 sequences — the dark signal on T2 reflects their dense collagen content and differentiates them from most malignant soft-tissue tumors, which are T2-bright.

Biopsy is not routinely performed for typical plantar fibromas — imaging is diagnostic in the vast majority of cases. Biopsy is reserved for atypical presentations (rapid growth, vascular signal on Doppler, indistinct margins on MRI) where fibrosarcoma or epithelioid sarcoma needs to be excluded.

Treatment Options

Treatment is indicated when the fibroma is symptomatic. Asymptomatic fibromas — even large ones — do not require treatment. The treatment ladder proceeds from least to most invasive.

• Offloading pads and orthotics: A custom orthotic with a fibroma relief cavity (a cutout directly under the nodule) eliminates direct ground pressure on the lesion with every step. This is the single most effective first-line intervention and often provides dramatic symptomatic relief. Many patients remain well-controlled with orthotics alone for years.
• Footwear modification: Shoes with a cushioned, conforming midsole (avoid flat, rigid soles) and a wide toe box reduce arch compression. Custom orthotics work best in shoes with a removable insole.
• Verapamil 15% topical gel: Applied twice daily directly over the fibroma, verapamil (a calcium channel blocker) inhibits fibroblast proliferation and collagen synthesis. Published case series show reduction in fibroma size in a subset of patients with 6 months of consistent use. It is safe, non-invasive, and worth a trial in motivated patients with small-to-medium fibromas.
• Corticosteroid injection: An ultrasound-guided injection into the fibroma reduces acute inflammatory pain and may modestly soften the nodule. It does not eliminate or significantly reduce fibroma size but can provide 3–6 months of comfort. We limit injections because repeated steroid exposure can weaken the plantar fascia.
• Collagenase injection (Xiaflex): Collagenase clostridium histolyticum — the same enzyme FDA-approved for Dupuytren’s contracture — has been used off-label for plantar fibromas with encouraging early results. The collagenase enzymatically disrupts the collagen-dense fibroma matrix, softening and potentially reducing the nodule. This is an emerging option in our practice for patients who want more than symptomatic management without surgery.
• Radiation therapy: Low-dose orthovoltage radiation (total 30–36 Gy in fractionated doses) has the strongest evidence for plantar fibromatosis / Ledderhose disease with multiple large nodules. Produces disease stabilization or regression in 80%+ of properly selected patients. Best used for Ledderhose disease before surgical intervention, as post-radiation surgical beds have better healing than post-operative recurrence beds.
• Surgical excision: Wide local excision of the fibroma — removing the nodule with a cuff of normal plantar fascia — is the most definitive treatment but carries significant recurrence risk (30–50% at 5 years) because residual fibromatous tissue in the fascia can regenerate. Total fasciectomy (complete plantar fascia removal) reduces recurrence but is a more extensive procedure with a longer recovery. Surgery is reserved for large, symptomatic fibromas that have failed conservative care, or for rapidly growing lesions requiring histological confirmation.

Plantar Fibroma vs. Plantar Fasciitis: How to Tell the Difference

These two conditions are frequently confused — both cause arch pain, and plantar fasciitis is far more common. The distinction matters because the treatments differ completely. Here is what separates them clinically:

	Plantar Fibroma	Plantar Fasciitis
What you feel	Firm, non-moveable lump in the arch	No lump — diffuse pain or tenderness
Pain pattern	Pressure-dependent; hurts when lump contacts ground	Worst with first steps in the morning, improves with walking
Location	Mid-arch, within the plantar fascia band	Heel and proximal arch, at fascia insertion
Worse with rest?	No — pain is mechanical (pressure on nodule)	Yes — classic post-static dyskinesia
Bilateral?	Often bilateral (25–50% of cases)	Can be bilateral but usually unilateral
X-ray / ultrasound	Hypoechoic nodule within fascia on ultrasound	Fascial thickening >4mm; plantar spur may be visible
First-line treatment	Fibroma-relief orthotic cavity + verapamil	Stretching, night splints, orthotics, NSAIDs

The key diagnostic test is simple: press directly on the tender spot. If you feel a firm, cord-like nodule embedded in the fascia that does not move laterally, that is a fibroma. If you cannot palpate a distinct mass, plantar fasciitis or another cause is more likely. An office ultrasound confirms the diagnosis in seconds.

Treatment Comparison: What Works, What Doesn’t, and Why

Not all treatments are equal, and the evidence behind each option varies considerably. This table summarizes what patients and clinicians should know before choosing a path:

Treatment	Evidence Level	Reduces Fibroma Size?	Pain Relief?	Best For
Fibroma-relief orthotics	High (clinical consensus)	No	Excellent	All symptomatic fibromas — first line
Verapamil 15% gel	Moderate (case series)	Possible (6+ months)	Moderate	Small-medium fibromas, motivated patients
Corticosteroid injection	Low-moderate	No	Good (3–6 months)	Acute pain flares; limited use
Collagenase (Xiaflex)	Emerging (off-label)	Yes (in subset)	Good	Medium fibromas, pre-surgical alternative
Radiation therapy	High (Ledderhose disease)	Yes (stabilizes/shrinks)	Good	Multiple nodules / Ledderhose disease
Surgical excision	High	Yes (removes nodule)	Excellent	Large, symptomatic, failed conservative care

The most common error we see: patients skipping directly to surgery without trialing verapamil or collagenase. Surgery carries a 30–50% recurrence rate at 5 years unless wide fasciectomy is performed, which is a significantly more involved procedure. Conservative and injectable options deserve a genuine trial first.

The Most Common Mistake We See

The most common mistake we see is patients (and occasionally providers) treating plantar fibromas as plantar fasciitis. The two conditions share arch-area pain and sometimes coexist, but they require different interventions. Plantar fascia stretching, night splints, and cortisone injections — the standard plantar fasciitis toolkit — do not address a fibrous nodule. The fibroma requires mechanical offloading from the nodule itself, not tension management of the fascia origin. Patients who have “failed plantar fasciitis treatment” for arch pain should be evaluated specifically for a fibroma — it is easily missed if the examiner is not palpating carefully along the full mid-arch of the fascia.

Frequently Asked Questions

Is a plantar fibroma dangerous?
Plantar fibromas are benign and do not metastasize. They are not cancerous. Fibrosarcoma (a malignant tumor) can theoretically arise in areas of fibromatosis, but this is extremely rare. Any rapidly growing, vascular, or atypical mass should be evaluated with imaging and possibly biopsy to exclude malignancy, but typical plantar fibromas are not dangerous.

Will a plantar fibroma go away on its own?
In a minority of patients, small fibromas remain stable or even regress spontaneously. More commonly, untreated fibromas slowly grow over time. They do not self-resolve in the majority of cases, but many patients manage them successfully with orthotics for years without progression requiring surgery.

What is the best treatment for plantar fibroma?
For symptom control, a fibroma-relief orthotic is the most reliably effective first step. For disease modification (actual reduction in fibroma size), verapamil gel and collagenase injection are the best evidence-supported non-surgical options. Surgery is the most definitive but carries meaningful recurrence risk.

The Bottom Line

Plantar fibromas are benign arch nodules embedded in the plantar fascia that cause pain from direct pressure during weight-bearing. They are diagnosed clinically and confirmed with ultrasound or MRI; biopsy is rarely needed. A fibroma-relief orthotic provides excellent symptomatic relief for most patients. Those who want to pursue size reduction have options ranging from verapamil gel to collagenase injection to radiation for extensive Ledderhose disease. Surgery is reserved for refractory cases. If you have a firm lump in your arch that is affecting your daily walking, come in — an accurate diagnosis and the right offloading intervention can restore your comfort quickly.

Sources:
1. Lee TH, et al. Plantar fibromatosis. J Am Acad Orthop Surg. 1993;1(1):11-17.
2. Veith NT, et al. Current concepts review: Plantar fibromatosis. Foot Ankle Int. 2013;34(12):1732-1737.
3. Pentland AP, Anderson TF. Plantar fibromatosis responds to intralesional steroids. J Am Acad Dermatol. 1985;12(1):212-214.

For a complete clinical overview: Our Complete Plantar Fascia & Foot Arch Guide — covers causes, diagnosis, treatment protocols & exercises from a Michigan board-certified podiatrist.